Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy
For context on how these results compare with single-agonist options, semaglutide (Wegovy) achieved 14.9% mean weight loss at 68 weeks in the STEP 1 trial, and retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, showed up to 24.2% weight loss in Phase 2
Klinic's experienced team in Duluth verifies insurance benefits, identifies coverage for Wegovy or other semaglutide brands, and manages the entire prior authorization process
These injuries can have a substantial impact on a persons mental, physical, and financial health
They have significant anxiety around the weight gain that they're experiencing. The Infant Risk Center at Texas Tech University, which provides guidance on medication safety while breastfeeding, also reports overwhelming interest from lactating women in taking semaglutide to control weight
